Year XX, N. 14, October 2017
Considerations about generic substitution of orphan drugs for the treatment of patients affected by rare diseases
Antonello Di Paolo
Department of Clinical and Experimental Medicine, Section of Pharmacology, University of Pisa, Pisa, Italy
Apri in pdf